Cargando…
Metformin alters therapeutic effects in the BALB/c tumor therapy model
BACKGROUND: Despite considerable medical proceedings, cancer is still a leading cause of death. Major problems for tumor therapy are chemoresistance as well as toxic side effects. In recent years, the additional treatment with the antidiabetic drug metformin during chemotherapy showed promising resu...
Autores principales: | Meyer, Felix B., Goebel, Sophie, Spangel, Sonja B., Leovsky, Christiane, Hoelzer, Doerte, Thierbach, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161985/ https://www.ncbi.nlm.nih.gov/pubmed/34044797 http://dx.doi.org/10.1186/s12885-021-08354-x |
Ejemplares similares
-
Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model
por: Meyer, Felix B., et al.
Publicado: (2021) -
Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model
por: Poburski, Doerte, et al.
Publicado: (2016) -
Improvement of the BALB/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies
por: Poburski, Doerte, et al.
Publicado: (2016) -
Tumor targeting with pH-responsive poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment
por: Hoelzer, Doerte, et al.
Publicado: (2018) -
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress
por: Marx, Christian, et al.
Publicado: (2022)